↓ Skip to main content

A phase I study of a dual PI3-kinase/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia

Overview of attention for article published in BMC Pharmacology and Toxicology, September 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
25 Mendeley